Babycue private limited is a spin-off healthcare start-up founded in the year 2021 and currently incubated at Kalinga Institute of Industrial Technology (KIIT-TBI), initially incubated at Yenepoya Technology Incubator (YTI). Here at Babycue, we are developing cost-effective point-of-care microfluidic paper-based testing platform by using lateral flow assay (LFA) approach for early diagnosis and differentiation of diarrheal infection i.e., bacterial from viral ones, based on specific biomarkers.
Services
Our Services
Childhood diarrhea is a second serious public health concern, despite availability of simple treatment, leading to child-growth retardness, antibiotic overconsumption, increasing deaths patterns, antimicrobial resistance (AMR) events and cost of treatment due to unavailability of early point-of-care testing facility to differentiate diarrhea for appropriate & early clinical-decision making for prescription of definitive treatment. Thus, there is an urgent unmet need to combat increasing cases by introducing early diagnosis tool for differentiating diarrhea helping in clinical decision-making to prescribe definitive treatment.
- Cost-effective
- Non-invasive
- DIY approach
- ASSURED (WHO) criteria
- Highly selective and specific
- Eco-friendly substrate
- Disposable
- Needs resource-limited setups
- Rapid on-spot qualitative detection of responsible biomarkers as a reliable inflammation indicator
Our ยต-PAD based diarrheal detection device exhibits USPs like
Team
Our Team
Founder and Director
Director